Patents Assigned to GE Healthcare Bio-Sciences Corp.
  • Publication number: 20090143570
    Abstract: The invention provides systems, methods and kits for the separation and/or purification of at least two cellular components selected from genomic DNA, RNA and proteins. The method includes first lysing a biological sample to generate an aqueous solution containing the cellular components; then applying the aqueous solution to a first mineral support under conditions for genomic DNA to bind; and collecting the flowthrough which contains unbound total RNA and proteins. The method further includes applying the flowthrough to a second mineral support under conditions for RNA to bind, and collecting the flowthrough which contains proteins. The genomic DNA and total RNA bound can be eluted while the protein in the flowthrough can be further purified. Further the total RNA isolated could be used to isolate small RNA such as microRNA.
    Type: Application
    Filed: November 25, 2008
    Publication date: June 4, 2009
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: Miao Jiang, Mark S. Briggs, Rohini Dhulipala, Yuyang Christine Cai, Renee E. Bruno
  • Publication number: 20080287305
    Abstract: This invention provides methods for nucleic acid analysis. A closed complex of nucleic acid template, nucleotide and polymerase can be formed during polymerase reaction, absent divalent metal ion. This is used to trap the labeled nucleotide complementary to the next template nucleotide in the closed complex. Detection of the label allows determination of the identity of this next correct nucleotide. Identification can be either in place, as part of the complex, or as the dye is eluted from the complex when the reaction cycle is completed by the addition of divalent metal ion. In this way, sequential nucleotides of a DNA can be identified, effectively determining the DNA sequence. This method can be applied to nucleic acid single molecules or to collections of identical or nearly identical sequence such as PCR products or clones. Multiple templates can be sequenced in parallel, particularly if they are immobilized on a solid support.
    Type: Application
    Filed: June 9, 2005
    Publication date: November 20, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: Carl W. Fuller, John R. Nelson
  • Patent number: 7452698
    Abstract: The present invention describes terminal phosphate blocked nucleoside polyphosphates that are stable at high temperature and their use in nucleic acid amplification and analysis. Current invention further describes charge modified terminal phosphate blocked nucleoside polyphosphates for improved incorporation and direct loading of nucleic acid sequencing reactions onto separating media.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: November 18, 2008
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Anup Sood, Shiv Kumar, Carl W. Fuller, John R. Nelson
  • Publication number: 20080264852
    Abstract: The present invention relates to filtration cassette, components thereof and methods of making them. A filtration cassette comprises a plurality of subassemblies of which at least one comprises a filter screen encompassed by two filter membranes or one filter membrane and an impermeable film which are joined together around their peripheries.
    Type: Application
    Filed: July 8, 2005
    Publication date: October 30, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: Martin J. Weinstein, Michelle D. Lyman
  • Publication number: 20080262741
    Abstract: Methods and apparatus for screening large numbers of chemical compounds and performing a wide variety of fluorescent assays, including live cell assays. The methods utilize a laser linescan confocal microscope with high speed, high resolution and multi-wavelength capabilities and real time data-processing. Imaging may be done at video-rates and with use of ultraviolet illumination.
    Type: Application
    Filed: February 8, 2008
    Publication date: October 23, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: TIMOTHY D. HARRIS, RICHARD L. HANSEN, WILLIAM KARSH, NEAL A. NICKLAUS, JAY K. TRAUTMAN
  • Patent number: 7402654
    Abstract: A purified recombinant DNA polymerase having high processivity and strand-displacement activity. An isolated nucleic acid that encodes the bacteriophage DNA polymerase. A kit and method for amplifying DNA is also disclosed.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: July 22, 2008
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Carl W. Fuller, Cuong Lam
  • Patent number: 7393640
    Abstract: The present invention describes methods of using terminal-phosphate-labeled nucleotides in the presence of a manganese salt to enhance their substrate properties towards various enzymes. Particularly described are methods of detecting a nucleic acid in a sample, based on the use of terminal-phosphate-labeled nucleotides as substrates for nucleic acid polymerases, in the presence of a manganese salt. Further provided are manganese complexes of terminal-phosphate-labeled nucleotides as well as terminal-phosphate-labeled nucleotides with new linkers with enhanced substrate properties.
    Type: Grant
    Filed: February 5, 2004
    Date of Patent: July 1, 2008
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Shiv Kumar, Mark McDougall, Anup Sood, John Nelson, Carl Fuller, John Macklin, Paul Mitsis
  • Publication number: 20080076911
    Abstract: Disclosed is a process for separating and/or purifying a nucleic acid by elution of the nucleic acid from anion exchange resins under conditions of high salt concentration and the presence in the eluant of an additive comprising guanidine, or a guanidine-like derivative. The process allows high recovery of nucleic acids from anion exchange resins without impairing the nucleic acid stability as compared with conventional ion exchange chromatographic procedures.
    Type: Application
    Filed: September 19, 2007
    Publication date: March 27, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: SIBYLLE HERZER, SUDHAKAR RAO TAKKELLAPATI, RAJESH AMBAT
  • Publication number: 20080076912
    Abstract: The invention provides an improved method for the purification of nucleic acid molecules, which method comprises generating a cellular lysate containing the nucleic acid; contacting the lysate with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid; followed by eluting the nucleic acid from the anion exchanger with an aqueous mobile phase comprising an elution solution; and desalting the eluted nucleic acid such that it is suitable for downstream applications. The improvement of the method includes providing the anion exchanger in a packed column, wherein the column is packed using a salt solution containing an antimicrobial agent. In addition, the salt solution has a salt concentration similar to that of the lysate, such that the column does not need equilibration prior to sample loading.
    Type: Application
    Filed: September 19, 2007
    Publication date: March 27, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: SUDHAKAR RAO TAKKELLAPATI, RAJESH AMBAT
  • Publication number: 20080076910
    Abstract: The invention provides an improved method for the purification of nucleic acid molecules, which method comprises generating a cellular lysate containing the nucleic acid; contacting the lysate with an anion exchanger bound to a solid support matrix under conditions such that the anion exchanger binds the nucleic acid; followed by eluting the nucleic acid from the anion exchanger with an aqueous mobile phase comprising an elution solution; and desalting the eluted nucleic acid such that it is suitable for downstream applications. The improvement of the method includes adding in the elution solution a composition such that the pH of the aqueous mobile phase is between about pH 9 and about pH 13, wherein the presence of the composition in the elution solution provides an increase in nucleic acid recovery, as compared with the recovery in the absence of the composition.
    Type: Application
    Filed: September 19, 2007
    Publication date: March 27, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: SUDHAKAR TAKKELLAPATI, RAJESH AMBAT
  • Publication number: 20080012577
    Abstract: A system for measuring parameters in a container is disclosed. A system for measuring multiple parameters includes a container having a solution, at least one sensor in conjunction with a tag is in proximity to an impedance analyzer and a reader that constitute a measurement device. The at least one sensor is configured to determine at least one parameter of the solution. The tag is configured to provide a digital ID associated with the sensor, where the container is in proximity to the reader and an impedance analyzer. The impedance analyzer is configured to send and receive a given range of frequencies from the sensor, based on the parameter and calculate parameter changes based on the response.
    Type: Application
    Filed: September 28, 2006
    Publication date: January 17, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: RADISLAV A. POTYRAILO, VINCENT F. PIZZI, HUA WANG
  • Publication number: 20080003602
    Abstract: Methods of amplification, purification and detection of nucleic acid sequences especially RNA are described. One aspect of the method involves the hybridisation and subsequent ligation of a nucleic acid structure to the nucleic acid sequence desired to be manipulated. The methods require that the nucleic acid structure comprises a double stranded region and a single stranded region. The single stranded region is complementary to the RNA sequence of interest. The double stranded region may also contain additional functionalities which are then used subsequently in the method.
    Type: Application
    Filed: December 22, 2005
    Publication date: January 3, 2008
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: John Nelson, R. Duthie, Rohini Dhulipala, Gregory Grossmann, Anuradha Sekher
  • Publication number: 20070292879
    Abstract: The present invention describes terminal phosphate blocked nucleoside polyphosphates that are stable at high temperature and their use in nucleic acid amplification and analysis. Current invention further describes charge modified terminal phosphate blocked nucleoside polyphosphates for improved incorporation and direct loading of nucleic acid sequencing reactions onto separating media.
    Type: Application
    Filed: July 24, 2007
    Publication date: December 20, 2007
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: ANUP SOOD, SHIV KUMAR, CARL FULLER, JOHN NELSON
  • Patent number: 7309571
    Abstract: This invention presents a new cDNA amplification method. RNA is first converted to cDNA. The synthesis of cDNA can include a promoter tagged oligonucleotide, and then this cDNA is ligated to form circles (or possibly concatemers). This is then amplified using a Phi29 DNA polymerase based rolling circle and strand displacement amplification. The invention allows for RNA promoter sequences to be attached to the cDNA to facilitate additional amplification through the generation of RNA from the amplified cDNA. The resulting product can then be used to make materials for gene expression studies or other RNA analysis procedures.
    Type: Grant
    Filed: February 3, 2004
    Date of Patent: December 18, 2007
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventor: John Nelson
  • Publication number: 20070269134
    Abstract: An apparatus, system, and method for generating an image are disclosed. A processor may generate a first output image based on a plurality of input images and remove an artefact, if any, from the first output image to generate a second output image. For example, in an embodiment, the processor may calculate a contribution of the artefact to image intensity values and subtract the calculated contribution from the image intensity values. In another embodiment, the processor may delete a predetermined portion of a transform image representing transform data obtained by applying an image transform to the first output image, thereby modifying the transform data, and may generate a non-transform image based on the modified transform data.
    Type: Application
    Filed: May 22, 2006
    Publication date: November 22, 2007
    Applicant: GE HEALTHCARE BIO-SCIENCES CORP.
    Inventors: Joseph J.O. Ruanaidh, Yang Zhang, Pierre Emeric, Marcin R. Swiatek, Vadim Rozenfeld
  • Patent number: 7264934
    Abstract: This invention provides methods for massive parallel nucleic acid analysis. A closed complex of nucleic acid template, nucleotide and polymerase can be formed during polymerase reaction, absent divalent metal ion. This is used to trap the nucleotide complementary to the next template nucleotide in the closed complex. Detection of the trapped nucleotide allows determination of the sequence of this next correct nucleotide. In this way, sequential nucleotides of a nucleic acid template can be identified, effectively determining the sequence. This method is applied to sequence multiple templates in parallel, particularly if they are immobilized on a solid support.
    Type: Grant
    Filed: October 21, 2005
    Date of Patent: September 4, 2007
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventor: Carl W. Fuller
  • Patent number: 7256019
    Abstract: The present invention describes terminal phosphate blocked nucleoside polyphosphates that are stable at high temperature and their use in nucleic acid amplification and analysis. Current invention further describes charge modified terminal phosphate blocked nucleoside polyphosphates for improved incorporation and direct loading of nucleic acid sequencing reactions onto separating media.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: August 14, 2007
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Anup Sood, Shiv Kumar, Carl Fuller, John Nelson
  • Patent number: 7244566
    Abstract: A method of characterizing an analyte sample is provided that includes the steps of: (a) anchoring the analyte to a nucleic acid template of known sequence; (b) conducting a DNA polymerase reaction that includes the reaction of a template, a non-hydrolyzable primer, at least one terminal phosphate-labeled nucleotide, DNA polymerase, and an enzyme having 3??5? exonuclease activity which reaction results in the production of labeled polyphosphate; (c) permitting the labeled polyphosphate to react with a phosphatase to produce a detectable species characteristic of the sample; (d) detecting the detectable species. The method may include the step of characterizing the nucleic acid sample based on the detection. Also provided are methods of analyzing multiple analytes in a sample, and kits for characterizing analyte samples.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: July 17, 2007
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Anup Sood, Shiv Kumar, Carl Fuller, John Nelson
  • Patent number: 7223541
    Abstract: The present invention relates to improved methods of detecting a target using a labeled substrate or substrate analog. The methods comprise reacting the substrate or substrate analog in an enzyme-catalyzed reaction which produces a labeled moiety with independently detectable signal only when such substrate or substrate analog reacts. The present invention, in particular, describes methods of detecting a nucleic acid in a sample, based on the use of terminal-phosphate-labeled nucleotides as substrates for nucleic acid polymerases. The methods provided by this invention utilize a nucleoside polyphosphate, dideoxynucleoside polyphosphate, or deoxynucleoside polyphosphate analogue which has a colorimetric dye, chemiluminescent, or fluorescent moiety, a mass tag or an electrochemical tag attached to the terminal-phosphate. When a nucleic acid polymerase uses this analogue as a substrate, an enzyme-activatable label would be present on the inorganic polyphosphate by-product of phosphoryl transfer.
    Type: Grant
    Filed: February 5, 2003
    Date of Patent: May 29, 2007
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Carl Fuller, Shiv Kumar, Anup Sood, John Nelson
  • Patent number: D554522
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: November 6, 2007
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Angel G. Obregon, III, Shelagh Ormiston